Nanocarriers made from non-ionic surfactants or natural polymers for pulmonary drug delivery.

Katharine Carter, Mireia Puig

Research output: Contribution to journalArticle

52 Downloads (Pure)

Abstract

Treatment by the pulmonary route can be used for administration of drugs that act locally in the lungs (e.g. treatment of lung cancer, chronic obstructive pulmonary disease, asthma) or non-invasive administration of drugs that act systemically. The potential of drug delivery systems formed from non-ionic surfactants or natural products i.e. proteins and polysaccharides for pulmonary delivery are discussed.
Original languageEnglish
Number of pages28
JournalCurrent Pharmaceutical Design
Publication statusAccepted/In press - 6 Dec 2015

Keywords

  • drug delivery systems
  • non-ionic surfactant vesicles
  • nanoparticles
  • pulmonary

Cite this